Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation

NCT: NCT05408754 · COMPLETED

NCT IDNCT05408754
StatusCOMPLETED
Start Date2022-10-20
Completion2025-03-03

Brief Summary

A prospective, two-arm, multi-center, randomized, open-label, pre-market, First-in-Human clinical study designed to provide safety and performance data regarding the use of the Adagio PFA and PFCA Systems in the treatment of PsAF.

Frequently Asked Questions

What is Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation?

Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation is a clinical trial registered under NCT05408754. Current status: COMPLETED.

What is the status of NCT05408754?

The current status of NCT05408754 (Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation) is: COMPLETED.

When did Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation start?

Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation started on 2022-10-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑